Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-studyA Riccio, Giorgio Walter Canonica, Pierluigi Mauri et al.|World Allergy Organization Journal|2020Cited by 23
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)Massimo Filippi, Roberto Vuotto, Roberta Messina et al.|Journal of Neurology|2023Cited by 12
Effectiveness of cyclosporine A in patients with moderate to severe plaque psoriasis in a real-life clinical setting in Italy: the TRANSITION studyFranco Marsili, R. Orsenigo, Massimo Travaglini et al.|Journal of Dermatological Treatment|2020Cited by 10
Proteomics analysis of asthma biomarkers: proxima sub-studyPierluigi Mauri, Giorgio Walter Canonica, Rossana Rossi et al.|Unknown|2017Cited by 1